CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Green Cross Corporation Company Snapshot
Green Cross Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Green Cross with three other companies in this sector in KOREA (SOUTH) : Celltrion HealthCare Co Ltd (2019 sales of 1.10 trillion Korean Won [US$946.76 million] of which 100% was Manufacture/Process/Sale of Medicine), Samsung Biologics Co Ltd (701.59 billion Korean Won [US$603.37 million] of which 100% was Biological Medicine Production), and Celltrion, Incorporation (1.13 trillion Korean Won [US$970.48 million] of which 87% was Bio Business Division).

Sales Analysis. Green Cross reported sales of 1.37 trillion Korean Won (US$1.18 billion) for the year ending December of 2019. This represents an increase of 2.6% versus 2018, when the company's sales were 1.33 trillion Korean Won . Sales at Green Cross have increased during each of the previous five years (and since 2014, sales have increased a total of 40%). Sales of Greencross Medis saw an increase that was more than double the company's growth rate: sales were up 35.5% in 2019, from 7.20 billion Korean Won to 9.75 billion Korean Won . Green Cross also saw significant increases in sales in Greencross Ms (up 9.0% to 94.09 billion Korean Won ) and Greencrosswb (up 24.2% to 66.94 billion Korean Won ) and Greencross Gclabcell (up 9.2% to 55.26 billion Korean Won ) and Greencross Genome (up 24.1% to 12.16 billion Korean Won ) . Not all segments of Green Cross experienced an increase in sales in 2019: sales of Invacfarm fell 16.7% to 15.45 billion Korean Won . (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Green Cross Corporation
  Stock Performance Chart for Green Cross Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 253,500
(Figures in Korean Won )
1 Week -1.6%   13 Weeks -6.8%  
4 Weeks 63.0%   52 Weeks 115.7%  
 
Green Cross Corporation Key Data:
  Ticker: 006280 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 1,369,709,726,800
(Year Ending Jan 2020).
Employees: 1,766
  Currency: Korean Won Market Cap: 2,893,240,623,000
  Fiscal Yr Ends: December Shares Outstanding: 11,413,178
  Share Type: Common Closely Held Shares: 6,189,517
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.